最新ニュース Aflac (NYSE:AFL) 株価情報

Aflac

Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Aflac Inc

First Trust Active Factor Large Cap ETF

Air France-KLM

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) has outperformed the market over the past 10 years by 2.3% on an annualized basis producing an average annual return of 13.66%. Currently, Aflac has a market capitalization of $57.66 billion. 
Buying $100 In AFL: If an investor had bought $100 of AFL stock 10 years ago, it would be worth $357.14 today based on a price of $103.57 for AFL at the time of writing.
<h3>Aflac's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736456452_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Aflac Stock In The Last 10 Years

JP Morgan analyst Jimmy Bhullar maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Neutral and raises the price target from $90 to $94.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Aflac, Raises Price Target to $94

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SCHW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$75.00</td>
<td>$32.8K</td>
<td>15.8K</td>
<td>2.0K</td>
</tr>
<tr>
<td>RKT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$11.00</td>
<td>$30.0K</td>
<td>3.7K</td>
<td>545</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$82.50</td>
<td>$123.6K</td>
<td>0</td>
<td>500</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$100.00</td>
<td>$26.6K</td>
<td>4.0K</td>
<td>408</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$280.00</td>
<td>$25.2K</td>
<td>15.5K</td>
<td>271</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$65.00</td>
<td>$25.4K</td>
<td>1.0K</td>
<td>191</td>
</tr>
<tr>
<td>FI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$220.00</td>
<td>$28.1K</td>
<td>244</td>
<td>172</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$180.00</td>
<td>$88.5K</td>
<td>835</td>
<td>108</td>
</tr>
<tr>
<td>AFL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$102.00</td>
<td>$39.0K</td>
<td>0</td>
<td>100</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$240.00</td>
<td>$52.6K</td>
<td>2.1K</td>
<td>27</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding SCHW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>), we observe a call option sweep with bullish sentiment. It expires in 10 day(s) on January 17, 2025. Parties traded 585 contract(s) at a $75.00 strike. This particular call needed to be split into 26 different trades to become filled. The total cost received by the writing party (or parties) was $32.8K, with a price of $56.0 per contract. There were 15802 open contracts at this strike prior to today, and today 2017 contract(s) were bought and sold. 
• Regarding RKT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), we observe a put option sweep with neutral sentiment. It expires in 10 day(s) on January 17, 2025. Parties traded 500 contract(s) at a $11.00 strike. This particular put needed to be split into 22 different trades to become filled. The total cost received by the writing party (or parties) was $30.0K, with a price of $60.0 per contract. There were 3727 open contracts at this strike prior to today, and today 545 contract(s) were bought and sold. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option sweep with bullish sentiment. It expires in 192 day(s) on July 18, 2025. Parties traded 463 contract(s) at a $82.50 strike. This particular call needed to be split into 33 different trades to become filled. The total cost received by the writing party (or parties) was $123.6K, with a price of $267.0 per contract. There were 0 open contracts at this strike prior to today, and today 500 contract(s) were bought and sold. 
• Regarding SQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>), we observe a call option sweep with bearish sentiment. It expires in 164 day(s) on June 20, 2025. Parties traded 35 contract(s) at a $100.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.6K, with a price of $762.0 per contract. There were 4083 open contracts at this strike prior to today, and today 408 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a call option sweep that happens to be bearish, expiring in 45 day(s) on February 21, 2025. This event was a transfer of 10 contract(s) at a $280.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $25.2K, with a price of $2536.0 per contract. There were 15520 open contracts at this strike prior to today, and today 271 contract(s) were bought and sold. 
• Regarding AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we observe a call option sweep with bearish sentiment. It expires in 45 day(s) on February 21, 2025. Parties traded 40 contract(s) at a $65.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $25.4K, with a price of $635.0 per contract. There were 1099 open contracts at this strike prior to today, and today 191 contract(s) were bought and sold. 
• Regarding FI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), we observe a call option sweep with neutral sentiment. It expires in 45 day(s) on February 21, 2025. Parties traded 131 contract(s) at a $220.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $28.1K, with a price of $215.0 per contract. There were 244 open contracts at this strike prior to today, and today 172 contract(s) were bought and sold. 
• For BX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), we notice a put option sweep that happens to be bullish, expiring in 10 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $180.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $88.5K, with a price of $885.0 per contract. There were 835 open contracts at this strike prior to today, and today 108 contract(s) were bought and sold. 
• Regarding AFL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>), we observe a call option trade with bullish sentiment. It expires in 31 day(s) on February 7, 2025. Parties traded 100 contract(s) at a $102.00 strike. The total cost received by the writing party (or parties) was $39.0K, with a price of $390.0 per contract. There were 0 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we notice a call option sweep that happens to be bearish, expiring in 374 day(s) on January 16, 2026. This event was a transfer of 18 contract(s) at a $240.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $52.6K, with a price of $2925.0 per contract. There were 2123 open contracts at this strike prior to today, and today 27 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AFRM

COIN

SCHW

10 Financials Stocks Whale Activity In Today's Session

During the last three months, 7 analysts shared their evaluations of Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $106.29, with a high estimate of $124.00 and a low estimate of $98.00. This current average reflects an increase of 4.38% from the previous average price target of $101.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1736200816_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Aflac is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$102.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$107.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$124.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$106.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$102.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Aflac. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Aflac compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Aflac's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Aflac's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AFL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Aflac analyst ratings.</a>
<h2>Unveiling the Story Behind Aflac</h2>
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
<h3>Aflac: Delving into Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, Aflac faced challenges, resulting in a decline of approximately -39.69% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Aflac's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -3.06%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Aflac's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.37%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Aflac's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.07%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.32.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Aflac: Insights From 7 Financial Analysts

Barclays analyst Alex Scott maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Underweight and raises the price target from $96 to $98.

Barclays Maintains Underweight on Aflac, Raises Price Target to $98

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) has outperformed the market over the past 10 years by 1.57% on an annualized basis producing an average annual return of 12.79%. Currently, Aflac has a market capitalization of $57.48 billion. 
Buying $100 In AFL: If an investor had bought $100 of AFL stock 10 years ago, it would be worth $333.03 today based on a price of $103.24 for AFL at the time of writing.
<h3>Aflac's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735074007_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analysts' ratings for Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) over the last quarter vary from bullish to bearish, as provided by 9 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Aflac and provided 12-month price targets. The average target is $105.33, accompanied by a high estimate of $124.00 and a low estimate of $90.00. Marking an increase of 5.59%, the current average surpasses the previous average price target of $99.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1733317232_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Aflac. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$102.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$107.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$124.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$106.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$102.00</td>
<td>-</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$122.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Underperform</td>
<td>$90.00</td>
<td>$84.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Aflac. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Aflac compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Aflac's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Aflac's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AFL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Aflac analyst ratings.</a>
<h2>All You Need to Know About Aflac</h2>
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
<h3>Financial Milestones: Aflac's Journey</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Aflac's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -39.69%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Aflac's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -3.06%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.37%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Aflac's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.07%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Aflac's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.32.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Aflac: Insights From 9 Analyst Reviews

Evercore ISI Group analyst Thomas Gallagher maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Underperform and lowers the price target from $104 to $102.

Evercore ISI Group Maintains Underperform on Aflac, Lowers Price Target to $102

Dividends

Aflac Increases Quarterly Dividend From $0.50 To $0.58

WIIM

Aflac shares are trading higher. Wells Fargo raised its price target on the stock from $106 to $107.

Wells Fargo analyst Elyse Greenspan maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Equal-Weight and raises the price target from $106 to $107.

Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $107

12 analysts have expressed a variety of opinions on Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Aflac, revealing an average target of $103.92, a high estimate of $124.00, and a low estimate of $90.00. This upward trend is evident, with the current average reflecting a 9.16% increase from the previous average price target of $95.20.
<img src="https://www.benzinga.com/files/images/story/2024/1730494849_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Aflac's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$124.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$106.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$102.00</td>
<td>-</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$122.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Underperform</td>
<td>$90.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Underweight</td>
<td>$96.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$98.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$109.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$90.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Aflac. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Aflac compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Aflac's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Aflac's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AFL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Aflac analyst ratings.</a>
<h2>Delving into Aflac's Background</h2>
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
<h3>Key Indicators: Aflac's Financial Health</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Challenges: Aflac's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -42.82%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -3.15%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Aflac's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.37%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Aflac's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.07%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Aflac's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.32.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Aflac

Truist Securities analyst Mark Hughes maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Hold and raises the price target from $100 to $105.

Truist Securities Maintains Hold on Aflac, Raises Price Target to $105

Aflac shares are trading lower after the company reported worse-than-expected Q3 revenue results. The company also announced a new President.

Management

Aflac Names Virgil Miller As President

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $1.68 by 30.36 percent. This is a 19.02 percent increase over earnings of $1.84 per share from the same period last year. The company reported quarterly sales of $2.95 billion which missed the analyst consensus estimate of $4.42 billion by 33.28 percent. This is a 40.42 percent decrease over sales of $4.95 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Aflac Q3 Adj $2.19 Beats $1.68 Estimate, Sales $2.95B Miss $4.42B Estimate

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) has outperformed the market over the past 5 years by 1.71% on an annualized basis producing an average annual return of 15.41%. Currently, Aflac has a market capitalization of $61.49 billion. 
Buying $100 In AFL: If an investor had bought $100 of AFL stock 5 years ago, it would be worth $206.47 today based on a price of $109.79 for AFL at the time of writing.
<h3>Aflac's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730134817_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

B of A Securities analyst Joshua Shanker maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Buy and raises the price target from $115 to $124.

B of A Securities Maintains Buy on Aflac, Raises Price Target to $124

Wells Fargo analyst Elyse Greenspan maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Equal-Weight and raises the price target from $90 to $106.

Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $106

TD Cowen analyst Andrew Kligerman initiates coverage on Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Hold rating and announces Price Target of $102.

Initiation

TD Cowen Initiates Coverage On Aflac with Hold Rating, Announces Price Target of $102

Wells Fargo's 'Core' List: GOOGL, DIS, HD, WMT, and more

Dividend Champion, Contender, And Challenger Highlights: Week Of December 8

On December 2, Aflac (AFL) increased its quarterly dividend by 16%, from 50¢ to 58¢ per share.

Aflac Dividend Increase

Piper Sandler analyst John Barnidge maintained a Buy rating on AFLAC (AFL – Research Report) today and set a price target of $122.00. The company's...

Piper Sandler Remains a Buy on AFLAC (AFL)

Chevron, Kimberly-Clark Among 15 Companies To Announce Dividend Increases In January

Value 10 screen from BofA as January 2025 equity trading launches

J.P. Morgan analyst Jimmy Bhullar maintained a Hold rating on AFLAC (AFL – Research Report) today. The company's shares closed yesterday at $101.79...

J.P. Morgan Keeps Their Hold Rating on AFLAC (AFL)

JPMorgan analyst Jimmy Bhullar raised the firm's price target on Aflac (AFL) to $94 from $90 and keeps a Neutral rating on the shares as part of a ...

Aflac price target raised to $94 from $90 at JPMorgan

Aflac's Shares Are Overvalued

Keefe Bruyette analyst Ryan Krueger lowered the firm's price target on Aflac (AFL) to $107 from $108 and keeps a Market Perform rating on the share...

Aflac price target lowered to $107 from $108 at Keefe Bruyette

AAPL

ACGL

AGCO

AMAT

AMCR

AMGN

APOG

AVGO

AVLV

AVNT

BCPC

BWXT

CADE

CARR

CASS

CBOE

CCFN

CFFI

CGDV

CINF

CMCSA

COFS

CRAI

CSCO

CSWC

CTAS

CTBI

CTVA

CUBE

CWEN

CZFS

EBAY

EBTC

EFSC

EQIX

ERIE

ESNT

EXPD

FAST

FELE

FISI

FSFG

GATX

GILD

GOOGL

GRMN

GWRS

HLAN

HLNE

HUBB

HWBK

KNSL

LCII

LCNB

LDOS

LRCX

LSTR

MAIN

MATW

MBIN

MGEE

MORN

MSFT

NBTB

ORCL

OTTR

PAYX

PFIS

PINE

RPRX

SAMG

SBAC

SBUX

SEIC

SLGN

SNDR

SNPS

SPGI

SSNC

SSTK

STLD

TRNO

TROW

TRUX

TSCO

TSX:AUM

TTEK

TXNM

UBCP

UBSI

UFPI

UNTY

VRSK

Insurance

Press Releases

Aflac Incorporated to Release Third Quarter Results and CFO Video Update on October 30, 2024 and Host Webcast on October 31, 2024

Transmit Security Powers Aflac's 2024 CSO Award Win for "Quackcess Granted" Passkey Authentication Initiative

Aflac Incorporated Promotes Virgil R. Miller to President of Aflac Incorporated, Audrey Boone Tillman and Max K. Brodén Elevated to Senior Executive Vice President

Aflac Incorporated Announces Third Quarter Results, Reports Third Quarter Net Losses of $93 Million, Declares Fourth Quarter Cash Dividend

Aflac hires JR Shamley as senior vice president, National Account Business Development and Growth Solutions

American workforce burnout reaches tipping point

Aflac Incorporated to Webcast 2024 Financial Analysts Briefing

My Special Aflac Duck® lands in the Sacramento Valley

Aflac Incorporated Announces 16.0% Increase in the First Quarter 2025 Dividend

Aflac Incorporated to Release Fourth Quarter Results and CFO Video Update on February 5, 2025 and Host Webcast on February 6, 2025

Comments

Aflac

ニュース

最新ニュース Aflac (NYSE:AFL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル